| 2401 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
67 |
| 2402 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
66 |
| 2403 |
Apheresis |
Allogeneic
|
Acute Myeloid Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
65 |
| 2404 |
Apheresis |
Autologous
|
Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
37 |
| 2405 |
Apheresis |
Allogeneic
|
Bare Lymphocyte Syndrome Type Ii
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
3 |
| 2406 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
66 |
| 2407 |
Apheresis |
Allogeneic
|
B-Cell Acute Lymphoblastic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
49 |
| 2408 |
Apheresis |
Autologous
|
B-Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
66 |
| 2409 |
Apheresis |
Allogeneic
|
B-Cell Precursor Acute Lymphocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
53 |
| 2410 |
Apheresis |
Allogeneic
|
B-Cell Precursor Acute Lymphocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
27 |
| 2411 |
Apheresis |
Allogeneic
|
B-Cell Precursor Acute Lymphocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
51 |
| 2412 |
Apheresis |
Allogeneic
|
Beta Thalassemia Major
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
4 |
| 2413 |
Apheresis |
Allogeneic
|
Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
66 |
| 2414 |
Apheresis |
Allogeneic
|
Cell Neoplasm
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
47 |
| 2415 |
Apheresis |
Allogeneic
|
Chronic Lymphocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
61 |
| 2416 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
43 |
| 2417 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
36 |
| 2418 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
62 |
| 2419 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
59 |
| 2420 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
37 |
| 2421 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
41 |
| 2422 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2423 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
61 |
| 2424 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
54 |
| 2425 |
Apheresis |
Allogeneic
|
Chronic Myelogenous Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
28 |
| 2426 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
62 |
| 2427 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
65 |
| 2428 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
64 |
| 2429 |
Apheresis |
Autologous
|
Composite Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
71 |
| 2430 |
Apheresis |
Allogeneic
|
Congenital Pulmonary Lymphangiectasia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
50 |
| 2431 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
59 |
| 2432 |
Apheresis |
Allogeneic
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
50 |
| 2433 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
70 |
| 2434 |
Apheresis |
Allogeneic
|
Ewing Sarcoma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
62 |
| 2435 |
Apheresis |
Autologous
|
Follicular Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
62 |
| 2436 |
Apheresis |
Allogeneic
|
Follicular Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
53 |
| 2437 |
Apheresis |
Allogeneic
|
Hemophagocytic Lymphohistiocytosis (Hlh)
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
4 |
| 2438 |
Apheresis |
Autologous
|
Hodgkin – Relapse
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
43 |
| 2439 |
Apheresis |
Allogeneic
|
Huntington’s Disease (Hd)
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
36 |
| 2440 |
Apheresis |
Allogeneic
|
Hypoplastic Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
27 |
| 2441 |
Apheresis |
Allogeneic
|
Immunodeficiency
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
4 |
| 2442 |
Apheresis |
Allogeneic
|
Inherited Immune System Disorder
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
16 |
| 2443 |
Apheresis |
Allogeneic
|
Langerhans Cell Sarcoma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
66 |
| 2444 |
Apheresis |
Autologous
|
Light-Chain Amyloidosis
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
62 |
| 2445 |
Apheresis |
Allogeneic
|
Macrofocal Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
94 |
| 2446 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
54 |
| 2447 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
64 |
| 2448 |
Apheresis |
Allogeneic
|
Mast Cell Sarcoma, Systemic Mastocytosis Nr
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
51 |
| 2449 |
Apheresis |
Allogeneic
|
Mixed Phenotype Acute Leukemia
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
64 |
| 2450 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
43 |
| 2451 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
57 |
| 2452 |
Apheresis |
Allogeneic
|
Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
71 |
| 2453 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
47 |
| 2454 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
53 |
| 2455 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
65 |
| 2456 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
60 |
| 2457 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2458 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2459 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
72 |
| 2460 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
61 |
| 2461 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
68 |
| 2462 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
54 |
| 2463 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
67 |
| 2464 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
69 |
| 2465 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
61 |
| 2466 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2467 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2468 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
61 |
| 2469 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
64 |
| 2470 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
69 |
| 2471 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
58 |
| 2472 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
56 |
| 2473 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
66 |
| 2474 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2475 |
Apheresis |
Allogeneic
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
56 |
| 2476 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
53 |
| 2477 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
66 |
| 2478 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
59 |
| 2479 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
59 |
| 2480 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
64 |
| 2481 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
63 |
| 2482 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
68 |
| 2483 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
60 |
| 2484 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
42 |
| 2485 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
62 |
| 2486 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
50 |
| 2487 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
59 |
| 2488 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
56 |
| 2489 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
64 |
| 2490 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2023
|
Standard Therapy
|
Germany
|
59 |
| 2491 |
Apheresis |
Allogeneic
|
Mycosis Fungoides
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
62 |
| 2492 |
Apheresis |
Allogeneic
|
Myelodysplastic Disorders
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2493 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
71 |
| 2494 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
64 |
| 2495 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
67 |
| 2496 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
56 |
| 2497 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
41 |
| 2498 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
70 |
| 2499 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
57 |
| 2500 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2023
|
Standard Therapy
|
Poland
|
70 |